CIK: 0001637359
Total reported value
$163.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NUVB | Nuvation Bio INC | Stock-Other | 25.27% | -4.02% | -8.49% | |
| 2 | BBOT | Bridgebio Oncology Therapeut | Stock-Other | 14.37% | +3.68% | — | |
| 3 | BBNX | Beta Bionics INC | Stock-Other | 14.00% | -5.92% | -31.45% | |
| 4 | BCAX | Bicara Therapeutics INC | Stock-Other | 12.95% | +16.21% | — | |
| 5 | KMTS | Kestra Medical Technologies, Ltd. | Stock-Other | 12.71% | -0.22% | -16.54% | |
| 6 | UPB | Upstream Bio INC | Stock-Other | 12.57% | -12.57% | EXIT | |
| 7 | ✓ | Engene Holdings INC | Stock-Other | 2.76% | +0.90% | +66.49% | |
| 8 | ALMS | Alumis INC | Stock-Other | 2.23% | +1.03% | — | |
| 9 | SANA | Sana Biotechnology INC | Stock-Other | 1.20% | +0.29% | — | |
| 10 | IMA | Imagenebio INC | Stock-Other | 1.10% | +0.30% | — | |
| 11 | REPL | Replimune Group INC | Stock-Other | 0.84% | +0.33% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NUVB | Nuvation Bio INC | +10.6% | -8.49% | Trim |
| 2 | ✓ | Engene Holdings INC | +1.1% | +66.49% | Add |
| 3 | UPB | Upstream Bio INC | +1.1% | -2.21% | Trim |
| 4 | ALMS | Alumis INC | +1.1% | — | Unchanged |
| 5 | REPL | Replimune Group INC | +0.4% | — | Unchanged |
| 6 | SANA | Sana Biotechnology INC | -0.2% | — | Unchanged |
| 7 | IMA | Imagenebio INC | -0.6% | — | Unchanged |
| 8 | BCAX | Bicara Therapeutics INC | -2.7% | — | Unchanged |
| 9 | BBOT | Bridgebio Oncology Therapeut | -2.8% | — | Unchanged |
| 10 | BBNX | Beta Bionics INC | -3.2% | -31.45% | Trim |
| 11 | KMTS | Kestra Medical Technologies, Ltd. | -4.9% | -16.54% | Trim |
| 12 | ✓ | Engene Holdings INC | — | EXIT | Sold out |